The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular and clinical characterization of BRAF mutations in pancreatic ductal adenocarcinomas (PDACs).
 
Michelle Guan
Research Funding - Halozyme (Inst)
 
R Joseph Bender
Employment - Perthera
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Sirtex Medical
Consulting or Advisory Role - Caris Life Sciences; Celgene; Perthera; Sirtex Medical
Research Funding - Celldex (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Perthera; Sirtex Medical
 
David Charles Halverson
Employment - Perthera
Leadership - Perthera
Research Funding - Perthera
Travel, Accommodations, Expenses - Perthera
 
Richard Tuli
No Relationships to Disclose
 
Samuel Jacob Klempner
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Celgene; Lilly
Speakers' Bureau - Foundation Medicine
Research Funding - Leap Therapeutics (Inst)
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Array BioPharma; Five Prime Therapeutics; Novartis; Sirtex Medical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech
 
Aatur D. Singhi
No Relationships to Disclose
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; D3D Inc.; Perthera
Consulting or Advisory Role - Ceres Nanosciences; Perthera; Zymeworks
Research Funding - Ceres Nanosciences (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Genentech; Ipsen; Novartis; Perthera
Travel, Accommodations, Expenses - Halozyme